Overview
Navid Hafez is a Hematologist Oncology specialist and an Oncologist in Los Angeles, California. Dr. Hafez is rated as an Experienced provider by MediFind in the treatment of Retroperitoneal Liposarcoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Large-Cell Lung Carcinoma.
His clinical research consists of co-authoring 19 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
11800 Wilshire Blvd, Los Angeles, CA 90025
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
The Regents Of The University Of California
Arun Singh is a Hematologist Oncology specialist and a Hematologist in Marina Del Rey, California. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Retroperitoneal Liposarcoma. His top areas of expertise are Retroperitoneal Liposarcoma, Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.
The Regents Of The University Of California
Bartosz Chmielowski is a Hematologist and an Oncologist in Los Angeles, California. Dr. Chmielowski is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Metastatic Uveal Melanoma, Vulvectomy, and Tissue Biopsy.
USC Care Medical Group Inc
Mark Agulnik is an Oncologist in Los Angeles, California. Dr. Agulnik is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Synovial Sarcoma, Angiosarcoma, Osteotomy, and Colonoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Hafez isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hafez isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Hafez isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hafez isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Ampullary CancerDr. Hafez isExperienced. Learn about Ampullary Cancer.
- AngiosarcomaDr. Hafez isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Hafez isExperienced. Learn about Bladder Cancer.
- Breast CancerDr. Hafez isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Hafez isExperienced. Learn about Breast Cancer in Men.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Hafez isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).